These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17010942)

  • 21. Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity.
    Tang C; Shou M; Rodrigues AD
    Drug Metab Dispos; 2000 May; 28(5):567-72. PubMed ID: 10772636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosynthesis of epoxyeicosatrienoic acids varies between polymorphic CYP2C enzymes.
    Lundblad MS; Stark K; Eliasson E; Oliw E; Rane A
    Biochem Biophys Res Commun; 2005 Feb; 327(4):1052-7. PubMed ID: 15652503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes: purification, cDNA cloning, and enzyme characterization.
    Sakamoto K; Kirita S; Baba T; Nakamura Y; Yamazoe Y; Kato R; Takanaka A; Matsubara T
    Arch Biochem Biophys; 1995 Jun; 319(2):372-82. PubMed ID: 7786018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.
    McGinnity DF; Berry AJ; Kenny JR; Grime K; Riley RJ
    Drug Metab Dispos; 2006 Aug; 34(8):1291-300. PubMed ID: 16679385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the main human cytochrome P450 enzymes involved in safrole 1'-hydroxylation.
    Ueng YF; Hsieh CH; Don MJ; Chi CW; Ho LK
    Chem Res Toxicol; 2004 Aug; 17(8):1151-6. PubMed ID: 15310247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone.
    Winter HR; Wang Y; Unadkat JD
    Drug Metab Dispos; 2000 Aug; 28(8):865-8. PubMed ID: 10901692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of CYP71B7, a cytochrome P450 expressed sequence Tag from Arabidopsis thaliana.
    Maughan JA; Nugent JH; Hallahan DL
    Arch Biochem Biophys; 1997 May; 341(1):104-11. PubMed ID: 9143359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate Specificity of Human Cytochrome P450 (CYP) 2C Subfamily and Effect of Azole Antifungal Agents on CYP2C8.
    Niwa T; Imagawa Y
    J Pharm Pharm Sci; 2016; 19(4):423-429. PubMed ID: 28057172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementary DNA cloning and characterization of cytochrome P450 2D29 from Japanese monkey liver.
    Hichiya H; Takemi C; Tsuzuki D; Yamamoto S; Asaoka K; Suzuki S; Satoh T; Shinoda S; Kataoka H; Narimatsu S
    Biochem Pharmacol; 2002 Oct; 64(7):1101-10. PubMed ID: 12234613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes.
    Li W; Liu Y; He YQ; Zhang JW; Gao Y; Ge GB; Liu HX; Huo H; Liu HT; Wang LM; Sun J; Wang Q; Yang L
    Xenobiotica; 2008 Dec; 38(12):1551-65. PubMed ID: 18982531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
    Kitamura A; Mizuno Y; Natsui K; Yabuki M; Komuro S; Kanamaru H
    Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily.
    Relling MV; Aoyama T; Gonzalez FJ; Meyer UA
    J Pharmacol Exp Ther; 1990 Jan; 252(1):442-7. PubMed ID: 2299601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lansoprazole enantiomer activates human liver microsomal CYP2C9 catalytic activity in a stereospecific and substrate-specific manner.
    Liu KH; Kim MJ; Jung WM; Kang W; Cha IJ; Shin JG
    Drug Metab Dispos; 2005 Feb; 33(2):209-13. PubMed ID: 15537834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity.
    Wan J; Imaoka S; Chow T; Hiroi T; Yabusaki Y; Funae Y
    Arch Biochem Biophys; 1997 Dec; 348(2):383-90. PubMed ID: 9434752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marmoset cytochrome P450 2D8 in livers and small intestines metabolizes typical human P450 2D6 substrates, metoprolol, bufuralol and dextromethorphan.
    Uehara S; Uno Y; Hagihira Y; Murayama N; Shimizu M; Inoue T; Sasaki E; Yamazaki H
    Xenobiotica; 2015; 45(9):766-72. PubMed ID: 25801057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone.
    Uno Y; Fujino H; Kito G; Kamataki T; Nagata R
    Mol Pharmacol; 2006 Aug; 70(2):477-86. PubMed ID: 16648389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism.
    Miners JO; Rees DL; Valente L; Veronese ME; Birkett DJ
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1076-81. PubMed ID: 7891318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA.
    Furuya H; Meyer UA; Gelboin HV; Gonzalez FJ
    Mol Pharmacol; 1991 Sep; 40(3):375-82. PubMed ID: 1896026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants.
    Melet A; Marques-Soares C; Schoch GA; Macherey AC; Jaouen M; Dansette PM; Sari MA; Johnson EF; Mansuy D
    Biochemistry; 2004 Dec; 43(49):15379-92. PubMed ID: 15581350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validated assays for human cytochrome P450 activities.
    Walsky RL; Obach RS
    Drug Metab Dispos; 2004 Jun; 32(6):647-60. PubMed ID: 15155557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.